Recent Publications on : |  |
Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach.
Mutations in the Parkin (PARK2) and PINK1 gene (PARK 6) can cause...
Direct Link | 31st October, 2009
| Department of Neurology, Donders Institute for Brain, Cognition and
|
Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
BACKGROUND AND PURPOSE: Mutations in leucine-rich repeat kinase 2 (LRRK2)...
Direct Link | 20th October, 2009
| Laboratorio de Investigaciones Biomedicas,, Servicio de Neurologia,
|
Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Summary Non-Hodgkin lymphomas (NHL) represent a frequent complication of...
Direct Link | 17th October, 2009
| Division of Haematology, Department of Clinical and Experimental Medicine
|
Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation.
Loss-of-function mutations in the parkin gene (PARK2) and PINK1 gene...
Direct Link | 7th October, 2009
| Neurobiochemistry, Deutsches Zentrum fur Neurodegenerative Erkrankungen
|
Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles.
Nanoparticles have received a great deal of attention for producing new...
Direct Link | 29th September, 2009
| Neurochemistry Laboratory, Division of Neurotoxicology, National Center
|
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.
Mutations in PINK1 and PARK2 cause autosomal recessive parkinsonism, a...
Direct Link | 24th September, 2009
| Medical Research Council Centre for Developmental and Biomedical Genetics,
|
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
The relative contribution of simple mutations and copy number variations...
Direct Link | 24th September, 2009
| Neurodegenerative Brain Diseases Group, Department of Molecular Genetics,
|
Detecting purely epistatic multi-locus interactions by an omnibus permutation test on ensembles of two-locus analyses.
BACKGROUND: Purely epistatic multi-locus interactions cannot generally be...
Direct Link | 19th September, 2009
| Department of Electrical Engineering, Faculty of Engineering, King
|
Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?
The occurrence of dementia in genetic Parkinson's disease is...
Direct Link | 11th September, 2009
| Department of Neurology, The Sagol Neuroscience Center, Sheba Medical
|
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
Dopa-responsive dystonia is a childhood-onset dystonic disorder,...
Direct Link | 10th September, 2009
| AP-HP, Departement de Genetique et Cytogenetique, Groupe Hospitalier Pitie
|
Hereditary parkinsonism: Parkinson disease look-alikes-An algorithm for clinicians to "PARK" genes and beyond.
In the past decade, a number of genetic causes of parkinsonism have been...
Direct Link | 8th September, 2009
| Department of Neurology, University of Lubeck, Lubeck, Germany.
|
Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
Among several etiological factors, PARK2 mutations are the most common...
Direct Link | 8th September, 2009
| Departments of Neurology, Post Graduate Institute of Medical Education and
|
Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood.
Research on Parkinson's disease fails to pinpoint a single gene or a gene...
Direct Link | 26th August, 2009
| Kocaeli University, Department
|
Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
OBJECTIVE: Mutations in the PARK2 (Parkin) gene result in an early-onset...
Direct Link | 25th July, 2009
| Department of Neurology, Faculty of Heath Science, Medical University of
|
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Glioblastoma multiforme (GBM) is an extremely malignant brain tumor. To...
Direct Link | 24th June, 2009
| Division of Hematology and Oncology, Cedars-Sinai Medical Center,
|
